Back to Search Start Over

Long-term mortality of Dutch COVID-19 patients admitted to the intensive care medicine: a retrospective analysis from a national quality registry.

Authors :
Wortel SA
Bakhshi-Raiez F
Abu-Hanna A
Dongelmans DA
Keizer NF
Houwink A
Dijkhuizen A
Draisma A
Rijkeboer A
Cloïn A
Meijer A
Reidinga A
Festen-Spanjer B
van Bussel B
Eikemans B
Jacobs C
Moolenaar D
Ramnarain D
Koning D
Boer D
Verbiest D
van Slobbe-Bijlsma E
van Koppen E
Rengers E
van Driel E
Verweij E
van Iersel F
Brunnekreef G
Kieft H
Kreeftenberg H
Hené I
Janssen I
Drogt I
van der Horst I
Spijkstra JJ
Rozendaal J
Mehagnoul-Schipper J
Erasmus JE
Holtkamp J
Lutisan J
van Oers J
Lens J
van Gulik L
van den Berg L
Urlings-Strop L
Georgieva L
van Lieshout M
Hoogendoorn M
Mos MV
Graaff M
Bruin M
Hoeksema M
van Tellingen M
Barnas M
Erkamp M
Gritters N
Kusadasi N
Elbers P
Koetsier P
Spronk P
van der Voort P
Pruijsten R
Jong R
Bosman RJ
Wesselink R
Schnabel R
van den Berg R
Waal R
Arbous S
Knape S
Hendriks S
Frenzel T
Dormans T
Rijpstra T
Silderhuis V
Ruijter W
Source :
Critical care science [Crit Care Sci] 2024 Dec 20; Vol. 36, pp. e202400251en. Date of Electronic Publication: 2024 Dec 20 (Print Publication: 2024).
Publication Year :
2024

Abstract

Objective: To describe the 12-month mortality of Dutch COVID-19 intensive care unit patients, the total COVID-19 population and various subgroups on the basis of the number of comorbidities, age, sex, mechanical ventilation, and vasoactive medication use.<br />Methods: We included all patients admitted with COVID-19 between March 1, 2020, and March 29, 2022, from the Dutch National Intensive Care (NICE) database. The crude 12-month mortality rate is presented via Kaplan-Meier survival curves for each patient subgroup. We used Cox regression models to analyze the effects of patient characteristics on 12-month mortality after hospital discharge.<br />Results: We included 16,605 COVID-19 patients. The in-hospital mortality rate was 28.1%, and the 12-month mortality rate after intensive care unit admission was 29.8%. Among hospital survivors, 12-month mortality after hospital discharge was 2.5% (300/11,931). The hazard of death at 12 months after hospital discharge was greater in patients between 60 and 79 years (HR 4.74; 95%CI 2.23 - 10.06) and ≥ 80 years (HR 22.77; 95%CI 9.91 - 52.28) than in patients < 40 years of age; in male patients than in female patients (HR 1.38; 95%CI 1.07 - 1.78); and in patients with one (adjusted HR 1.95; 95%CI 1.5 - 2.53), two (adjusted HR 4.49; 95%CI 3.27 - 6.16) or more than two comorbidities (adjusted HR 4.99; 95%CI 2.62 - 9.5) than in patients with no comorbidities. Neither vasoactive medication use nor mechanical ventilation resulted in statistically significant results.<br />Conclusion: For Dutch COVID-19 intensive care unit patients, most deaths occurred during their hospital stay. For hospital survivors, the crude 12-month mortality rate was low. Patient age (older than 60), sex and the number of comorbidities were associated with a greater hazard of death at 12 months after hospital discharge, whereas mechanical ventilation and vasoactive medication were not.

Details

Language :
English; Portuguese
ISSN :
2965-2774
Volume :
36
Database :
MEDLINE
Journal :
Critical care science
Publication Type :
Academic Journal
Accession number :
39775432
Full Text :
https://doi.org/10.62675/2965-2774.20240251-en